NDC 81284-315

BLUDIGO

Indigotindisulfonate Sodium

BLUDIGO is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Provepharm Inc.. The primary component is Indigotindisulfonate Sodium.

• Product ID: 81284-315_193c5468-f781-4d5c-b6cf-881533009398
• NDC: 81284-315
• Product Type: Human Prescription Drug
• Proprietary Name: BLUDIGO
• Generic Name: Indigotindisulfonate Sodium
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2022-09-06
• Marketing Category: NDA /
• Application Number: NDA216264
• Labeler Name: Provepharm Inc.
• Substance Name: INDIGOTINDISULFONATE SODIUM
• Active Ingredient Strength: 8 mg/mL
• Pharm Classes: Diagnostic Dye [EPC], Dyes [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 81284-315-05

5 AMPULE in 1 CARTON (81284-315-05) > 5 mL in 1 AMPULE (81284-315-00)

• Marketing Start Date: 2022-09-06
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details